Exercise Intervention for Colorectal Cancer Survivors
Trial Summary
What is the purpose of this trial?
This trial evaluates the effects a moderate-to-vigorous exercise intervention has on the bacterial make-up of the gastrointestinal tract (gut microbiota) in survivors of stage II-III colorectal cancer (CRC). Data shows that the gut microbiota composition and function may be drivers of CRC. High levels of exercise are associated with improved CRC prognosis and survival. While data suggests that exercise has the potential to influence gut microbiota composition and function, it is not known whether these effects contribute to improved CRC prognosis. This clinical trial evaluates the effects an exercise intervention has on gut microbiota and how these effects relate to CRC progression and patient-reported outcomes.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants who have used antibiotics, antifungals, or antiparasitics in the past 6 months.
What data supports the effectiveness of the treatment Exercise Intervention for Colorectal Cancer Survivors?
Is exercise intervention safe for colorectal cancer survivors?
How does the exercise intervention treatment for colorectal cancer survivors differ from other treatments?
The exercise intervention for colorectal cancer survivors is unique because it focuses on improving physical fitness and quality of life through regular physical activity, which can reduce cancer recurrence risk and improve overall health, unlike traditional treatments that primarily target cancer cells directly.458910
Research Team
Heather Greenlee
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Eligibility Criteria
This trial is for stage II-III colorectal cancer survivors aged 18-70, with a BMI of 18.5-30, not currently smoking or pregnant, and within 60 days to 3 years post-cancer treatment. Participants must be able to exercise, have smartphone access, and commit to attending the study sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a supervised exercise intervention or health-related information over 8 weeks. Blood samples are collected at baseline and week 8.
Follow-up
Participants are monitored for retention, adherence, and acceptability of the intervention.
Treatment Details
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator